[Use of defibrotide in the treatment of Raynaud's phenomenon associated with progressive systemic sclerosis or essential mixed cryoglobulinemia]. [electronic resource]
- La Clinica terapeutica Sep 1988
- 335-43 p. digital
Publication Type: Comparative Study; English Abstract; Journal Article
0009-9074
Adolescent Adult Cryoglobulinemia--complications Drug Evaluation Fibrinolytic Agents--therapeutic use Humans Middle Aged Polydeoxyribonucleotides--therapeutic use Raynaud Disease--complications Scleroderma, Systemic--complications